清心泻肝安神方联合帕罗西汀治疗心肝火旺型广泛性焦虑伴失眠临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749.05

基金项目:


Clinical Study on Qingxin Xiegan Anshen Prescription Combined with Paroxetine for Generalized Anxiety Disorder Complicated with Insomnia of Effulgent Heart-Liver Fire Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清心泻肝安神方联合帕罗西汀治疗心肝火旺型广泛性焦虑(GAD) 伴失眠的临床效果。 方法:选取GAD伴失眠患者128例,按随机数字表法分为安神组和对照组各64例。对照组给予盐酸帕罗西汀 片口服,安神组在对照组基础上予清心泻肝安神方治疗,2组均治疗8周。评价2组临床疗效,比较2组治疗前 后中医证候评分、匹兹堡睡眠质量指数(PSQI) 量表评分、睡眠功能失调性信念与态度量表中文版(DBAS-CV) 评分、抑郁自评量表(SDS) 评分、广泛性焦虑量表(GAD-7) 评分,检测2 组血清去甲肾上腺素(NE)、 5-羟色胺(5-HT)、多巴胺(DA) 水平,记录2组不良反应发生情况。结果:治疗后,安神组总有效率为 95.31%,高于对照组84.38%(P<0.05)。治疗后,2组各项中医证候评分、PSQI评分、SDS评分、GAD-7评分 较治疗前降低(P<0.05),且安神组各项中医证候评分、PSQI评分、SDS评分、GAD-7评分低于对照组(P< 0.05)。治疗后,2 组DBAS-CV 评分较治疗前升高(P<0.05);且安神组DBAS-CV 评分高于对照组(P< 0.05)。治疗后,2组血清NE、DA水平较治疗前降低,5-HT水平较治疗前升高(P<0.05);且安神组血清NE、 DA水平低于对照组,5-HT水平高于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P> 0.05)。结论:清心泻肝安神方联合帕罗西汀治疗心肝火旺型GAD伴失眠的效果良好,能有效降低患者焦虑情 绪,改善睡眠状况,且不良反应少。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Qingxin Xiegan Anshen Prescription combined with Paroxetine on generalized anxiety disorder (GAD) complicated with insomnia of effulgent heart-liver fire type. Methods: A total of 128 cases of patients with GAD complicated with insomnia were selected and divided into the Anshen group and the control group with 64 cases respectively according to random number table method. The control group was given the oral administration of Paroxetine Hydrochloride Tablets,and the Anshen group was additionally treated with Qingxin Xiegan Anshen Prescription based on the treatment of the control group. Both groups were treated for eight weeks. The clinical effects in the two groups were evaluated; traditional Chinese medicine (TCM) syndrome scores, Pittsburgh Sleep Quality Index (PSQI) scores,Dysfunctional Beliefs and Attitudes about Sleep Scale-Chinese Version (DBAS-CV) scores,Selfrating Depression Scale (SDS) scores, and Generalized Anxiety Disorder-7 (GAD-7) scores in the two groups were compared before and after treatment. The levels of noradrenaline (NE),5-hydroxytryptamine (5-HT) and dopamine (DA) in serum in the two groups were detected;the occurrence of adverse reactions in the two groups were recorded. Results: After treatment, the total effective rate was 95.31% in the Anshen group,higher than that of 84.38% in the control group (P<0.05). After treatment,TCM syndrome scores,PSQI scores,SDS scores and GAD-7 scores in the two groups were decreased when compared with those before treatment (P<0.05),and the above scores in the Anshen group were lower than those in the control group (P<0.05). After treatment, DBAS-CV scores in the two groups were increased when compared with those before treatment (P<0.05),and the DBAS-CV score in the Anshen group was higher than that in the control group (P<0.05). After treatment, the levels of NE and DA in serum in the two groups were declined when compared with those before treatment,and 5-HT levels were elevated when compared with those before treatment (P<0.05); the levels of NE and DA in serum in the Anshen group were lower than those in the control group,and the level of serum 5-HT was higher than that in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Qingxin Xiegan Anshen Prescription combined with Paroxetine has a good effect on the treatment of GAD complicated with insomnia of effulgent heart-liver fire type, which can effectively reduce the anxiety of patients and improve sleep status,with fewer adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

熊飞,王义,席三赢.清心泻肝安神方联合帕罗西汀治疗心肝火旺型广泛性焦虑伴失眠临床研究[J].新中医,2024,56(19):60-65

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-10-14
  • 出版日期:
文章二维码